Efficacy of hydroxyurea in providing transfusion independence in β-thalassemia. (mở cửa sổ mới)

Ansari SH, Shamsi TS, Ashraf M, Perveen K, Farzana T, Bohray M, Erum S, Mehboob T.

Nguồn‎: J Pediatr Hematol Oncol 2011;33(5):339-43.

Mã bài‎: PubMed 21602718

DOI‎: 10.1097/MPH.0b013e31821b0770

https://www.ncbi.nlm.nih.gov/pubmed/21602718 (mở cửa sổ mới)

Hydroxyurea treatment in β-thalassemia patients: to respond or not to respond? (mở cửa sổ mới)

Banan M.

Nguồn‎: Ann Hematol 2013;92(3):289-99.

Mã bài‎: PubMed 23318979

DOI‎: 10.1007/s00277-012-1671-3

https://www.ncbi.nlm.nih.gov/pubmed/23318979 (mở cửa sổ mới)

Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia. (mở cửa sổ mới)

Bradai M, Pissard S, Abad MT, Dechartres A, Ribeil JA, Landais P, de Montalembert M.

Nguồn‎: Transfusion 2007;47(10):1830-6.

Mã bài‎: PubMed 17880608

DOI‎: 10.1111/j.1537-2995.2007.01399.x

https://www.ncbi.nlm.nih.gov/pubmed/17880608 (mở cửa sổ mới)

Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease. (mở cửa sổ mới)

Fucharoen S, Siritanaratkul N, Winichagoon P, Chowthaworn J, Siriboon W, Muangsup W, Chaicharoen S, Poolsup N, Chindavijak B, Pootrakul P, Piankijagum A, Schechter AN, Rodgers GP.

Nguồn‎: Blood 1996;87(3):887-92.

Mã bài‎: PubMed 8562958

https://www.ncbi.nlm.nih.gov/pubmed/8562958 (mở cửa sổ mới)

Hydroxyurea can reduce or eliminate transfusion requirements in children with major and intermediate thalassemia. (mở cửa sổ mới)

Hashemi A, Abrishamkar M, Jenabzade AR, Eslami Z.

Nguồn‎: Iran J Blood Cancer 2009;1(4):147-50.

Mã bài‎: IMEMR 107228

https://www.ijbc.ir/browse.php?a_id=4&sid=1&slc_lang=en (mở cửa sổ mới)

Hydroxyurea as a first-line treatment of extramedullary hematopoiesis in patients with beta thalassemia: Four case reports. (mở cửa sổ mới)

Karimi M, Cohan N, Pishdad P.

Nguồn‎: Hematology 2015;20(1):53-7.

Mã bài‎: PubMed 24717020

DOI‎: 10.1179/1607845414Y.0000000168

https://www.ncbi.nlm.nih.gov/pubmed/24717020 (mở cửa sổ mới)

Genotype-phenotype relationship of patients with β-thalassemia taking hydroxyurea: a 13-year experience in Iran. (mở cửa sổ mới)

Karimi M, Haghpanah S, Farhadi A, Yavarian M.

Nguồn‎: Int J Hematol 2012;95(1):51-6.

Mã bài‎: PubMed 22180324

DOI‎: 10.1007/s12185-011-0985-6

https://www.ncbi.nlm.nih.gov/pubmed/22180324 (mở cửa sổ mới)

Report on Patients with Non Transfusion-Dependent β-Thalassemia Major Being Treated with Hydroxyurea Attending the Thalassemia Research Center, Sari, Mazandaran Province, Islamic Republic of Iran in 2013. (mở cửa sổ mới)

Kosaryan M, Karami H, Zafari M, Yaghobi N.

Nguồn‎: Hemoglobin 2014;38(2):115-8.

Mã bài‎: PubMed 24471558

DOI‎: 10.3109/03630269.2013.869229

https://www.ncbi.nlm.nih.gov/pubmed/24471558 (mở cửa sổ mới)

Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia. (mở cửa sổ mới)

Musallam KM, Taher AT, Cappellini MD, Sankaran VG.

Nguồn‎: Blood 2013;121(12):2199-212.

Mã bài‎: PubMed 23315167

DOI‎: 10.1182/blood-2012-10-408021

https://www.ncbi.nlm.nih.gov/pubmed/23315167 (mở cửa sổ mới)

A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia. (mở cửa sổ mới)

Yasara N, Wickramarathne N, Mettananda C, Silva I, Hameed N, Attanayaka K, Rodrigo R, Wickramasinghe N, Perera L, Manamperi A, Premawardhena A, Mettananda S

Nguồn‎: Sci Rep. 2022;12(1):2752.

Mã bài‎: PubMed 35177777

DOI‎: 10.1038/s41598-022-06774-8

https://pubmed.ncbi.nlm.nih.gov/35177777/ (mở cửa sổ mới)

Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients. (mở cửa sổ mới)

Yavarian M, Karimi M, Bakker E, Harteveld CL, Giordano PC.

Nguồn‎: Haematologica 2004;89(10):1172-8.

Mã bài‎: PubMed 15477200

https://www.ncbi.nlm.nih.gov/pubmed/15477200 (mở cửa sổ mới)

Hydroxyurea therapy in 49 patients with major beta-thalassemia. (mở cửa sổ mới)

Zamani F, Shakeri R, Eslami SM, Razavi SM, Basi A.

Nguồn‎: Arch Iran Med 2009;12(3):295-7.

Mã bài‎: PubMed 19400608

https://www.ncbi.nlm.nih.gov/pubmed/19400608 (mở cửa sổ mới)

Preliminary results with administration of recombinant human erythropoietin in sickle cell/beta-thalassemia patients during pregnancy. (mở cửa sổ mới)

Bourantas K, Makrydimas G, Georgiou J, Tsiara S, Lolis D.

Nguồn‎: Eur J Haematol 1996;56(5):326-8.

Mã bài‎: PubMed 8641410

https://www.ncbi.nlm.nih.gov/pubmed/8641410 (mở cửa sổ mới)

Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy. (mở cửa sổ mới)

Breymann C, Fibach E, Visca E, Huettner C, Huch A, Huch R.

Nguồn‎: J Matern Fetal Med 1999;8(1):1-7.

Mã bài‎: PubMed 10052837

DOI‎: 10.1002/(SICI)1520-6661(199901/02)8:1<1::AID-MFM1>3.0.CO;2-O

https://www.ncbi.nlm.nih.gov/pubmed/10052837 (mở cửa sổ mới)

Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules. (mở cửa sổ mới)

Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E, Bourantas KL.

Nguồn‎: Acta Haematol 2004;111(4):189-95.

Mã bài‎: PubMed 15153710

DOI‎: 10.1159/000077551

https://www.ncbi.nlm.nih.gov/pubmed/15153710 (mở cửa sổ mới)

Recombinant human erythropoietin therapy in a transfusion-dependent β-thalassemia major patient. (mở cửa sổ mới)

Makis AC, Chaliasos N, Hatzimichael EC, Bourantas KL.

Nguồn‎: Ann Hematol 2001;80(8):492-5.

Mã bài‎: PubMed 11563599

https://www.ncbi.nlm.nih.gov/pubmed/11563599 (mở cửa sổ mới)

Fetal globin induction--can it cure beta thalassemia? (mở cửa sổ mới)

Perrine SP.

Nguồn‎: Hematology Am Soc Hematol Educ Program 2005:38-44.

Mã bài‎: PubMed 16304357

DOI‎: 10.1182/asheducation-2005.1.38

https://www.ncbi.nlm.nih.gov/pubmed/16304357 (mở cửa sổ mới)